NCT04578522 is a clinical trial in Premature Coronary Heart Disease, sponsored by Chongqing Medical University.

Who is sponsoring NCT04578522?

NCT04578522 is sponsored by Chongqing Medical University.

What condition does NCT04578522 study?

NCT04578522 studies Premature Coronary Heart Disease.

Is NCT04578522 still recruiting?

NCT04578522 is currently status unknown. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT04578522

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between the Severity of Coronary Artery Disease and Peripheral Arterial Stiffness in Patients With Premature Coronary Heart Disease

Status unknown Last updated 8 October 2020

What this trial tests

trial in Premature Coronary Heart Disease in 200 participants. Status unknown.

Timeline

29 September 2020

Primary endpoint
29 September 2021

29 September 2021

Quick facts

Lead sponsor	Chongqing Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	29 September 2020
Primary completion	29 September 2021
Estimated completion	29 September 2021
Sites	1 location across China

Conditions studied

Premature Coronary Heart Disease — all drugs for Premature Coronary Heart Disease →

Sponsor

Chongqing Medical University

Who can join

Eligibility, any sex, with Premature Coronary Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Premature coronary heart disease (CHD) refers to the onset of myocardial infarction in men \< 55 years old, women \< 65 years old. At present, researches on early-onset coronary heart disease mostly focus on its risk factors and clinical characteristics, but there is no relevant research on the relationship between early-onset myocardial infarction and atherosclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Premature Coronary Heart Disease

Currently open trials in the same condition.

NCT07031531 — Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease · NA · recruiting

Other Chongqing Medical University trials

Trials by the same sponsor.

NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT07503509 — Physiological Study of High PEEP in Noninvasive Ventilation · NA · recruiting
NCT06118671 — The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community · NA · unknown
NCT06272032 — Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis · EARLY_PHASE1 · unknown
NCT05974566 — Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04578522 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chongqing Medical University
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04578522.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing